PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care
Recent data from the National Family Health Survey (NFHS-6) 2023-24 reveals that lifestyle diseases, particularly diabetes and hypertension, are escalating rapidly across Maharashtra, with urban centers bearing the brunt of this crisis. The survey shows that 17.7% of men and 16% of women now have high blood sugar levels or are on diabetes medication—a significant jump from 13.6% and 12.4% respectively in NFHS-5 . In urban areas, the prevalence is even higher, with 20.4% of men and 19.3% of women affected, meaning nearly one in five urban adults is living with diabetes.
The burden of hypertension is equally alarming. Overall, 27.7% of men and 24.9% of women have elevated blood pressure or are on medication. Among urban men, the figure touches 30% —nearly one in three men in Maharashtra’s cities is living with hypertension, while urban women record a prevalence of 26%. The NFHS-5 survey had already established Maharashtra’s diabetes prevalence at 13%, with urban areas showing 15% prevalence. District-level analysis from NFHS-5 revealed that Sindhudurg had the highest prevalence at 23.4% among men and 20.6% among women, followed by Mumbai Suburban (21% men, 19.7% women). The state also has a concerning prevalence of abdominal obesity—51.5% of urban women and 43.2% of urban men have increased waist-hip ratio, a key risk factor for diabetes and heart disease .
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Maharashtra families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Maharashtra
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Maharashtra patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Maharashtra
Daksh works with hospitals, clinics, and pharmacies across Maharashtra to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The PCD pharma market in Maharashtra offers low investment (starting at approximately ₹25,000) with high profit margins and monopoly rights in selected areas.
Popular Locations for PCD Pharma Franchise in Maharashtra
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Mumbai | Cardiac diabetic PCD company in Mumbai |
| PCD pharma franchise in Pune | Cardiac diabetic products in Pune |
| PCD pharma franchise in Nagpur | Diabetic cardiac PCD franchise in Nagpur |
| PCD pharma franchise in Nashik | Cardiac diabetic PCD company in Nashik |
| PCD pharma franchise in Aurangabad | Cardiac diabetic products in Aurangabad |
| PCD pharma franchise in Thane | Diabetic cardiac PCD franchise in Thane |
| PCD pharma franchise in Kolhapur | Cardiac diabetic PCD company in Kolhapur |
| PCD pharma franchise in Solapur | Cardiac diabetic products in Solapur |
| PCD pharma franchise in Dhule | Diabetic cardiac PCD franchise in Dhule |
| PCD pharma franchise in Jalgaon | Cardiac diabetic PCD company in Jalgaon |
Conclusion
The diabetes and heart disease epidemic in Maharashtra is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 17.7% among men and 16% among women, hypertension affecting 30% of urban men, and the highest number of US FDA-approved pharma plants in India, the burden and the opportunity are both immense. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |